↓ Skip to main content

Do Parkinson’s disease patients disclose their adverse events spontaneously?

Overview of attention for article published in European Journal of Clinical Pharmacology, December 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
6 X users
facebook
1 Facebook page

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
61 Mendeley
Title
Do Parkinson’s disease patients disclose their adverse events spontaneously?
Published in
European Journal of Clinical Pharmacology, December 2011
DOI 10.1007/s00228-011-1198-x
Pubmed ID
Authors

Santiago Perez-Lloret, María Verónica Rey, Nelly Fabre, Fabienne Ory, Umberto Spampinato, Jean-Louis Montastruc, Olivier Rascol

Abstract

Underreporting of adverse drug reactions is common but has been rarely studied in Parkinson's disease (PD).

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Canada 1 2%
Unknown 59 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 16%
Student > Ph. D. Student 10 16%
Other 9 15%
Student > Master 8 13%
Student > Bachelor 4 7%
Other 8 13%
Unknown 12 20%
Readers by discipline Count As %
Medicine and Dentistry 18 30%
Psychology 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Neuroscience 5 8%
Nursing and Health Professions 3 5%
Other 9 15%
Unknown 16 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2012.
All research outputs
#5,824,127
of 23,911,072 outputs
Outputs from European Journal of Clinical Pharmacology
#671
of 2,645 outputs
Outputs of similar age
#50,054
of 249,756 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#10
of 31 outputs
Altmetric has tracked 23,911,072 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,645 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,756 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.